Fri, April 19, 2024
Thu, April 18, 2024
Wed, April 17, 2024

Matthew Kaplan Reiterated (TGTX) at Strong Buy and Held Target at $39 on, Apr 18th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-39-on-apr-18th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Kaplan of Ladenburg Thalmann, Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $39 on, Apr 18th, 2024.

Matthew has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Increased Target to $13 on, Thursday, February 29th, 2024


This is the rating of the analyst that currently disagrees with Matthew


  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $29 on, Monday, February 5th, 2024

Publication Contributing Sources